Request PowerPoint
PowerPoint animations are preserved in the original file.
Slide index (74)
- Loading slide titles…
Loading presentation…
Slide text will appear here when the presentation loads.
Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.
Lecture topics
- The organisms: A clinicopathologic map
- Mechanism predicts phenotype
- Anatomic progression can threaten the airway
- Chronic rheumatic disease: Scarring reshapes valves
- Group A versus group B: Clinical discrimination
- Infective endocarditis: Vegetations differ from scarring
- Enterococcal pathogenicity is not mainly exotoxin driven
- Primary reading
Slide index & full transcript (74 slides)
Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.
Slide 1 · Streptococcal and Enterococcal Infections
Mechanisms · Morphology · Clinicopathologic correlations
Streptococci and enterococci: distinct pathogens, overlapping lesions
Dr Abu Suraih Sakhri
MBBS, MD (Pathology)
www.abusuraihsakhri.com
Slide 2 · Learning objectives
Classify clinically important streptococci and enterococci by disease setting.
Connect virulence factors with inflammatory and immune-mediated injury.
Recognize characteristic tissue reactions, complications, and diagnostic clues.
Explain enterococcal persistence and vancomycin resistance.
Slide 3 · The organisms: A clinicopathologic map
Organism
Major disease context
Dominant theme
S. pyogenes (group A)
Pharyngitis; skin disease; postinfectious syndromes
Toxin, phagocyte evasion, autoimmunity
S. agalactiae (group B)
Chorioamnionitis; neonatal sepsis/meningitis
Maternal–neonatal infection
S. pneumoniae
Pneumonia; meningitis
Capsule and pneumolysin
Viridans / S. mutans
Endocarditis; dental caries
Oral flora and plaque
Enterococcus spp.
Healthcare-associated UTI; bacteremia; endocarditis
Persistence and antibiotic resistance
Slide 4 · Gram-positive cocci: Arrangement is a clue, not a species ID
Pairs
Chains
Shared Gram-positive coccal morphology
Schematic — not an authentic clinical or histologic specimen
Streptococci and enterococci grow as cocci in pairs or chains.
Enterococci can resemble streptococci on routine morphology.
Culture and organism identification establish the etiology.
Slide 5 · Hemolysis and antigens organize the streptococci
Group
Organisms
Teaching implication
β-hemolytic; group A
S. pyogenes
Pharyngitis, scarlet fever, skin infection
β-hemolytic; group B
S. agalactiae
Maternal colonization; neonatal infection
α-hemolytic
S. pneumoniae
Encapsulated pneumonia and meningitis
α- or nonhemolytic
Viridans streptococci
Oral flora; infective endocarditis
Slide 6 · Same broad morphology, different clinical niches
Bacterial group
Source or niche
Illustrative consequence
Group A streptococci
Oropharynx and skin disease
Acute suppuration; immune sequelae
Group B streptococci
Female genital tract
Pregnancy and neonatal infection
Pneumococcus
Respiratory tract
Consolidating pneumonia; meningitis
Viridans streptococci
Oral microbiota
Endocarditis; dental plaque
Enterococci
Gut commensals
Healthcare-associated UTI and invasive infection
Slide 7 · Two mechanisms of disease must be separated
Acute bacterial infection
Host inflammatory response
Tissue injury / dysfunction
Postinfectious rheumatic fever and glomerulonephritis instead follow immune responses to prior streptococcal infection.
Slide 8 · Virulence factors linked to injury
Organism
Factor
Consequences
S. pyogenes
Capsule; M protein; C5a peptidase
Impaired phagocytosis / recruitment
S. pyogenes
Pyrogenic exotoxin
Fever and scarlet-fever rash
S. pneumoniae
Capsule; pneumolysin
Resistance to phagocytosis; cell lysis
S. mutans
Acid + glucans
Enamel demineralization; bacterial plaque
Enterococci
Capsule, biofilm, enzymes
Persistence and host tissue injury
Slide 9 · Capsules impair phagocyte clearance
Capsular barrier
Phagocyte
Encapsulation → less efficient engulfment
Schematic — not an authentic clinical or histologic specimen
Capsules are present in S. Pyogenes, S. Agalactiae, and S. Pneumoniae.
Antiphagocytic surface protection favors persistence despite host defenses.
The pneumococcal capsule is its principal virulence factor.
Slide 10 · S. Pyogenes M protein: Surface-mediated evasion
M protein at surface
Reduced phagocytosis
Bacterial survival
M-protein–directed adaptive immunity also links prior group A infection to rheumatic heart disease.
Slide 11 · C5a peptidase blunts neutrophil recruitment
Bacterial C5a peptidase
Degradation of C5a
Less chemotactic signaling
C5a is a complement-derived chemoattractant; Its degradation weakens early inflammatory recruitment.
Slide 12 · A toxin-mediated syndrome: Scarlet fever
S. Pyogenes pharyngitis
Phage-encoded pyrogenic exotoxin
Fever + characteristic rash
The rash is a toxin-associated manifestation, not simply a map of bacteria spreading through skin.
Slide 13 · Mechanism predicts phenotype
Mechanistic pattern
Characteristic example
Pathologic interpretation
Antiphagocytic surface
Capsule and M protein
Persistent viable bacteria
Toxin-related
Pyrogenic exotoxin
Fever and rash
Direct destructive infection
Necrotizing fasciitis
Rapidly progressive soft-tissue necrosis
Postinfectious immune injury
Rheumatic fever / GN
Disease after preceding infection
Slide 14 · Group A streptococcus: Disease spectrum
Oropharyngeal infection: Pharyngitis with possible suppurative extension.
Skin infection: Impetigo and erysipelas with a neutrophilic tissue reaction.
Toxin-associated disease: Scarlet fever and toxic shock syndrome.
Severe invasive phenotype: Rapidly progressive necrotizing fasciitis.
Slide 15 · Most streptococcal lesions are diffusely neutrophilic
Epidermis
Dermis
Subcutis
Diffuse interstitial neutrophils
Schematic — not an authentic clinical or histologic specimen
Typical pattern: Interstitial neutrophils and tissue edema.
Compared with destructive abscess-forming patterns, necrosis is often limited.
Virulent necrotizing fasciitis is an important exception.
Slide 16 · Erysipelas: The clinical boundary matters
Rapidly spreading erythematous swelling, often involving the face.
A sharp, well-demarcated, serpiginous edge is characteristic.
Facial disease may produce a bilateral “butterfly” distribution.
Extremity or truncal involvement is also described.
Slide 17 · Erysipelas: Superficial tissue reaction
Epidermis
Dermis
Subcutis
Inflamed upper skin
Schematic — not an authentic clinical or histologic specimen
Diffuse edema and neutrophilic inflammation involve dermis and epidermis.
Inflammation can extend into subcutaneous tissue.
Microabscesses may occur; Overt necrosis is generally minor.
Slide 18 · Erysipelas morphology from cause to appearance
Streptococcal skin infection
Dermal edema + neutrophils
Red, raised, sharply bounded swelling
The outline of erythema is a clinical clue; The tissue response explains swelling and warmth.
Slide 19 · Skin manifestations: Shared versus exceptional features
Feature
Typical streptococcal lesion
Necrotizing fasciitis
Inflammatory cells
Interstitial neutrophils
Severe invasive inflammation
Tissue destruction
Usually relatively limited
Rapidly progressive tissue necrosis
Clinical pattern
Impetigo / erysipelas
Rapidly progressive soft-tissue disease
Interpretive caution
Surface appearance may mimic staph
Do not extrapolate “minor necrosis”
Slide 20 · Impetigo and skin infection: Avoid morphology alone
Overlap between streptococcal and staphylococcal skin lesions.
Shared appearances do not establish the microbiologic species.
Use an organism-directed diagnostic approach when etiology matters.
Slide 21 · Streptococcal pharyngitis: Gross features
Edema and swelling in the oropharyngeal region.
Punctate suppurative foci in the tonsillar crypts.
Cervical lymphadenopathy may accompany the infection.
Marked swelling can threaten airway patency.
Slide 22 · Tonsillar crypt abscesses: Focal pus within inflammation
Tonsillar crypt
Punctate crypt exudate
Schematic — not an authentic clinical or histologic specimen
Punctate abscesses form in the tonsillar crypts.
Local edema and lymphoid reactivity can enlarge tonsils.
The site of the inflammatory exudate explains focal pale spots.
Slide 23 · Anatomic progression can threaten the airway
Pharyngitis / swelling
Peritonsillar or retropharyngeal abscess
Airway encroachment
Severe pharyngeal swelling is important because obstruction is a structural complication, not just pain.
Slide 24 · Scarlet fever: Clinical distribution
Occurs in association with S. Pyogenes pharyngitis.
Punctate erythematous rash favors the trunk and inner limbs.
Facial involvement with relative circumoral pallor is characteristic.
During recovery, skin may become scaly and hyperkeratotic.
Slide 25 · Scarlet fever: Localization of the rash
Trunk: Prominent punctate rash
Inner limbs: Involved
Around mouth: Relatively spared
Schematic — not an authentic clinical or histologic specimen
A generalized toxin-associated eruption is most prominent over trunk and proximal limbs.
Relative sparing around the mouth creates circumoral pallor.
Desquamation occurs as fever subsides.
Slide 26 · Erysipelas and scarlet fever are not the same rash
Feature
Erysipelas
Scarlet fever
Primary setting
Localized skin infection
Associated with GAS pharyngitis
Distribution
Sharply bounded expanding plaque
Diffuse punctate eruption
Histopathology
Edematous neutrophilic dermatitis
Rash attributed to pyrogenic exotoxin
Characteristic clue
Serpiginous edge
Circumoral pallor / later scaling
Slide 27 · Necrotizing fasciitis: The severe invasive phenotype
Some highly virulent S. Pyogenes strains cause rapidly progressive fascial infection.
Necrosis—not merely a dense neutrophilic infiltrate—defines the danger.
Clinical progression may far exceed the apparent initial surface findings.
Slide 28 · Why immune sequelae appear after infection
Group A infection
Development of specific immunity
Cross-reactivity or immune complexes
A temporal gap and a second pathogenic mechanism distinguish postinfectious disease from local suppuration.
Slide 29 · Rheumatic fever: Molecular mimicry
Group A M protein
Cross-reactive antibody / T cell
Cardiac antigen recognition
Immune-mediated injury without myocardial bacteria
Schematic — not an authentic clinical or histologic specimen
Antibodies and CD4+ T cells against streptococcal M proteins recognize cardiac antigens.
Complement and recruited immune cells produce cardiac inflammation.
Bacteria are absent from the rheumatic cardiac lesions.
Slide 30 · Rheumatic fever follows an immune-response interval
Group A infection
About 2–3 weeks
Acute rheumatic inflammatory disease
The latency is compatible with time needed to mount cross-reactive adaptive immune responses.
Slide 31 · Aschoff bodies: The signature cardiac lesion
Activated macrophages + lymphocytes
Schematic — not an authentic clinical or histologic specimen
A focal aggregate contains T lymphocytes and activated macrophages.
Anitschkow cells display a central ribbon-like (“caterpillar”) nuclear chromatin pattern.
The lesion reflects immune-mediated myocardial inflammation, not bacterial colonies.
Slide 32 · Rheumatic carditis spans three heart layers
Site
Acute inflammatory consequence
Pericardium
Pericarditis
Myocardium
Myocarditis and Aschoff bodies
Endocardium / valves
Valvulitis, fibrinoid necrosis, small verrucae
Slide 33 · Chronic rheumatic disease: Scarring reshapes valves
Acute valvulitis
Healing with fibrosis
Leaflet thickening · commissural fusion · chordal shortening
Schematic — not an authentic clinical or histologic specimen
Mitral leaflets thicken and commissures fuse.
Chordae tendineae shorten, thicken, and may fuse.
Valve deformity produces chronic dysfunction, especially mitral stenosis.
Slide 34 · Endocarditis has two different streptococcal contexts
Feature
Poststreptococcal rheumatic valvulitis
Infective endocarditis
Driver
Cross-reactive host immunity
Microbial colonization of valve
Organisms within lesion
Absent
Present in infective vegetation
Main morphologic clue
Small verrucae and later fibrosis
Friable, potentially destructive vegetation
Example
Group A postinfectious disease
Viridans streptococci / enterococci
Slide 35 · Poststreptococcal glomerulonephritis: Immune complexes
Streptococcal antigen + antibody
Glomerular immune deposits
Complement + leukocyte injury
The disease is postinfectious: Immune-mediated glomerular inflammation follows pharyngeal or skin infection.
Slide 36 · Poststreptococcal GN: Timing and setting
Typically appears 1–4 weeks after a throat or skin infection.
Occurs most frequently in childhood but may affect other age groups.
The lag is consistent with antibody production and immune-complex formation.
Slide 37 · Postinfectious GN: A glomerular morphologic triad
Glomerular capillary loops + deposits
Schematic — not an authentic clinical or histologic specimen
Light microscopy: Diffuse endocapillary proliferation and leukocyte infiltration.
Immunofluorescence: Granular IgG/C3 pattern.
Electron microscopy: Characteristic subepithelial humps.
Slide 38 · Immune injury: Distinguish rheumatic fever from GN
Feature
Rheumatic fever
Poststreptococcal GN
Major target
Heart (including valves)
Glomeruli
Dominant immune mechanism
Cross-reactive antibodies and T cells
Immune complexes
Morphology
Aschoff bodies; valvulitis
Proliferative GN; granular deposits
Persistent bacterial invasion
No
No required glomerular infection
Slide 39 · Nephritic syndrome connects pathology to symptoms
Inflamed glomerular capillary loops lead to hematuria and red-cell casts.
Glomerular injury may produce proteinuria and edema.
Fluid retention and altered renal hemodynamics contribute to hypertension.
Slide 40 · Group B streptococcus: The obstetric reservoir
S. Agalactiae is a group B streptococcus.
It colonizes the female genital tract.
During pregnancy, ascending infection may cause chorioamnionitis.
Neonatal sepsis and meningitis are major clinical consequences.
Slide 41 · Group B disease may affect mother or neonate
Female genital tract colonization
Maternal chorioamnionitis
Neonatal sepsis / meningitis
Distinct maternal and neonatal syndromes
Schematic — not an authentic clinical or histologic specimen
Female genital tract carriage is the maternal reservoir.
Maternal chorioamnionitis and neonatal invasive disease are distinct outcomes.
Neonatal sepsis and meningitis are especially important presentations.
Slide 42 · Group B streptococcus: Capsule and invasive disease
Capsular barrier
Phagocyte
Encapsulation → less efficient engulfment
Schematic — not an authentic clinical or histologic specimen
S. Agalactiae has an antiphagocytic capsule.
A vulnerable neonatal host may develop disseminated infection.
Clinical setting and identification both matter: Appearance is not enough.
Slide 43 · Group A versus group B: Clinical discrimination
Feature
S. pyogenes (A)
S. agalactiae (B)
Representative source
Pharynx / skin infections
Female genital tract carriage
Typical context
Pharyngitis, erysipelas, scarlet fever
Chorioamnionitis; neonatal sepsis
Shared virulence
Antiphagocytic capsule
Antiphagocytic capsule
Distinct late sequelae
Rheumatic fever / PSGN
Not emphasized in the source
Slide 44 · Pneumococcus: Capsule plus pneumolysin
Capsular barrier
Phagocyte
Pneumolysin → host-cell lysis
Schematic — not an authentic clinical or histologic specimen
The capsule is the principal pneumococcal virulence factor.
Pneumolysin inserts into membranes and lyses host cells.
The combination promotes persistence and tissue damage.
Slide 45 · Pneumolysin amplifies the inflammatory injury
S. Pneumoniae in lung
Membrane injury by pneumolysin
Increased parenchymal damage
The toxin is distinct from the antiphagocytic effect of the polysaccharide capsule.
Slide 46 · Pneumococcal pneumonia: An alveolar exudate
S. Pneumoniae is a major cause of community-acquired acute pneumonia.
Bacterial invasion fills alveolar spaces with inflammatory exudate.
Accumulation of alveolar exudate causes airspace consolidation.
Slide 47 · Lobar consolidation: Why the lung becomes solid
Air space
Exudate / consolidation
Air replaced by inflammatory material
Schematic — not an authentic clinical or histologic specimen
Normal alveolar spaces are air-filled.
Acute bacterial exudate replaces air with neutrophils and protein-rich fluid.
Confluent involvement produces a consolidated lung region.
Slide 48 · Pneumococcal diagnosis: Sample and inference
Test / finding
Interpretation
Limitation
Sputum Gram stain
Lancet-shaped gram-positive diplococci with neutrophils
Airway colonization can confound
Blood culture
A specific invasive-disease clue when positive
Insensitive early in some cases
Clinical / radiology
Identifies pneumonia syndrome
Alone cannot reliably define organism
Slide 49 · Host vulnerability to encapsulated pneumococci
Defective or absent splenic function increases susceptibility to encapsulated bacteria.
Extremes of age, chronic illnesses, and immunodeficiency predispose to pneumonia.
An antiphagocytic capsule explains the importance of host clearance mechanisms.
Slide 50 · Pneumococcal prevention targets the capsule
Pneumococcal vaccines include polysaccharide and conjugate formulations.
Vaccines are recommended for young children, older adults, and selected risk groups.
Capsule-directed immunity reduces vulnerability to invasive pneumococcal infection.
Slide 51 · Pneumococcus also causes meningitis
S. Pneumoniae causes meningitis in children and adults.
Clinical presentation and the site of infection define the diagnostic workup.
A single organism can cause both pulmonary and central nervous system disease.
Slide 52 · Viridans streptococci: Oral residents, valvular pathogens
The viridans group comprises α-hemolytic and nonhemolytic streptococci.
They are normal components of oral microbiota.
They are a common cause of infective endocarditis.
Slide 53 · Infective endocarditis: Vegetations differ from scarring
Attached infective vegetation
Simplified valve surface — not an anatomical cross-section
Schematic — not an authentic clinical or histologic specimen
Viridans endocarditis can produce large, friable valve vegetations.
The lesion is microbial and potentially embolic.
It is not synonymous with sterile rheumatic verrucae.
Slide 54 · Valve infection generates systemic hazards
Infected valve vegetation
Valvular dysfunction / embolization
Sepsis and organ injury
The heart-valve lesion creates both local mechanical disease and distant infectious consequences.
Slide 55 · Infective endocarditis: Clinicopathologic diagnosis
Evidence combines microbiology with valve/implant imaging and examination.
Repeated blood cultures and anatomic evidence support the diagnosis.
Embolic and immunologic phenomena provide additional clues.
Slide 56 · S. Mutans: The metabolic pathway to dental caries
Sucrose fermentation
Lactic acid production
Enamel demineralization
Acid production is a direct biochemical route from oral carbohydrate metabolism to tooth destruction.
Slide 57 · S. Mutans: Glucans stabilize dental plaque
High-molecular-weight glucans
Bacterial aggregation
Plaque retention
Glucan-mediated adherence and acid production reinforce the cariogenic niche.
Slide 58 · Two viridans-related clinical pathways
Context
S. mutans caries
Viridans endocarditis
Setting
Tooth surface; oral plaque
Heart valve
Key mechanism
Acid + glucan biofilm matrix
Valve colonization with vegetations
Main damage
Demineralization of enamel
Valve dysfunction and embolism
Slide 59 · Enterococci: Commensals with invasive potential
Enterococci normally inhabit the gut.
E. Faecalis and E. Faecium are the main clinical species.
They produce urinary, wound, intraabdominal, bloodstream, and valve infections.
Pairs or chains do not reliably separate them from streptococci.
Slide 60 · Enterococcal clinical burden: Interpret context
Setting
Clinical significance
Hospital-associated UTI
Enterococci are major nosocomial uropathogens
Bloodstream infection
Bacteremia may have serious outcomes
Infective endocarditis
A significant cause of valve infection
Immunosuppressed hosts
Increased risk, particularly after transplantation
Slide 61 · Enterococcal biofilm: Persistence on a surface
Adherent bacterial community
Surface
Schematic — not an authentic clinical or histologic specimen
An antiphagocytic capsule contributes to biofilm formation.
Adherent communities support persistent colonization.
Tissue-damaging enzymes contribute to host injury.
Slide 62 · Transplant recipients: Converging infection risks
Immunosuppression
Frequent antibiotics
Altered gut microbiota
Higher enterococcal infection risk
Schematic — not an authentic clinical or histologic specimen
Immunosuppression impairs host defense.
Frequent antimicrobial exposure selects altered microbial communities.
Changes in commensal microbiota coexist with enterococcal infection risk.
Slide 63 · Enterococcal pathogenicity is not mainly exotoxin driven
Streptococcal strategy
Enterococcal strategy
Pyrogenic exotoxin / pneumolysin
No comparable toxin repertoire in Robbins account
Capsular immune evasion
Antiphagocytic capsule and biofilm
Immune complications after group A infection
Persistence and antimicrobial resistance
Species-specific tissue injury
Tissue-damaging enzymes
Slide 64 · Intrinsic and acquired resistance coexist
Intrinsic resistance
Mobile genetic elements
Acquired resistance traits
Reduced antimicrobial options
Schematic — not an authentic clinical or histologic specimen
Enterococci have intrinsic resistance to several antibiotic classes.
Additional resistance can be transferred on mobile genetic elements.
Both mechanisms contribute to difficult-to-treat infection.
Slide 65 · VanA changes the vancomycin binding target
D-Ala—D-Ala
D-Ala—D-Lac
VanA-associated substitution
Reduced vancomycin affinity
Schematic — not an authentic clinical or histologic specimen
VanA-associated resistance alters the cell-wall peptide terminus.
D-Ala–D-Ala is replaced by D-Ala–D-Lac.
The altered terminus has reduced affinity for vancomycin.
Slide 66 · VanA mechanism: Molecular cause and consequence
Step
Cell-wall precursor
Vancomycin consequence
Usual target
D-Ala–D-Ala
High-affinity binding target
vanA-associated alteration
D-Ala–D-Lac
Reduced vancomycin binding
Phenotypic effect
Modified precursor is used
Resistance mechanism
Slide 67 · Resistance is not a species identification test
E. Faecalis and E. Faecium both require organism-level identification.
Resistance phenotype must be determined separately from Gram morphology.
Antimicrobial-resistance mechanisms are clinically consequential but do not define the inflammatory lesion.
Slide 68 · Laboratory logic: Choose samples by syndrome
Syndrome
Diagnostic direction
Key caution
Streptococcal pharyngitis
Culture or rapid group A antigen test
A clinical rash alone is insufficient
Pneumonia
Respiratory specimens; selected blood cultures
Colonization can confound sputum
Suspected endocarditis
Blood culture and cardiac imaging
Requires clinicopathologic integration
Enterococcal infection
Culture with species and susceptibility
Morphology alone is nonspecific
Slide 69 · Clinicopathologic application: Pharyngitis plus rash
Case
A school-age child develops pharyngitis and fever, followed by a fine punctate erythematous eruption and relative circumoral pallor.
Which virulence factor links the infection to the systemic rash?
Discuss before revealing the explanation in speaker notes
Slide 70 · Clinicopathologic application: Delayed renal syndrome
Case
A child has hematuria and edema several weeks after a sore throat. Kidney biopsy shows endocapillary neutrophils and granular immunodeposits.
What explains the delay and glomerular injury?
Discuss before revealing the explanation in speaker notes
Slide 71 · Clinicopathologic application: A transplant recipient
Case
An immunosuppressed stem-cell transplant recipient develops a culture-confirmed enterococcal bloodstream infection despite repeated antibiotic courses.
What two source-supported factors favor this setting?
Discuss before revealing the explanation in speaker notes
Slide 72 · Final diagnostic contrasts
Entity
Mechanism / hallmark
Important consequence
Group A streptococcus
Pyogenic + toxin + immune sequelae
Erysipelas, scarlet fever, RF, GN
Group B streptococcus
Genital colonization; capsule
Maternal / neonatal invasive disease
Pneumococcus
Capsule + pneumolysin
Pneumonia and meningitis
Viridans / S. mutans
Oral flora, glucans, acid
Endocarditis or caries
Enterococci
Biofilm + antibiotic resistance
Healthcare-associated infection
Slide 73 · Take-home synthesis
Streptococcal syndromes range from local suppuration to toxin-mediated and delayed immune injury.
Organism identity, anatomic site, and virulence mechanism jointly predict the tissue lesion.
Enterococcal disease is distinguished by gut origin, healthcare exposure, biofilm, and resistance.
A schematic teaches mechanism; Microbiologic assays and true specimens establish diagnoses.
Slide 74 · Primary reading
Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th edition (2026).
Topic section: Streptococcal and Enterococcal Infections.
Relevant discussions of rheumatic heart disease, postinfectious glomerulonephritis, pneumonia, and infective endocarditis.
Related organ-system chapters clarify cardiac, pulmonary, renal, and oral manifestations.